MTOR and myotonic dystrophy type 1: Western blot results showed that the levels of LC3II/LC3I in DM1-03 (Fig. 5d, e) and DM1-13-3 SSCs (Fig. 5i, j) decreased after mTOR overexpression, and there were no differences from DM1-04 SSCs (Fig. 5k, l).